induced by hypertension. However, the role of this system on myocyte remodeling remains unclear. In the present study, we have assessed the effect of perindopril, an angiotensin converting enzyme (ACE) inhibitor, in spontaneously hypertensive rats (SHRs) as a means to evaluate the role of RAS in myocyte remodeling. We also investigated the effect of blockade on myocyte remodeling. We used female SHRs at 
Introduction
Cardiac pressure overloading during a period of compensated hypertrophy leads to increased ventricular wall thickness. According to the law of Laplace, ventricular wall stress is in proportion to chamber diameter and inversely proportional to wall thickness (1) . Thus, myocardial remodeling can be characterized as an adaptive morphological change, since the increase of relative ventricular wall thickness (ventricle wall thickness/ventricle diameter) is associated with a reduction in wall stress. And in the Framingham study, an increase in left ventricular mass (measured by echocardiography) predicted a higher incidence of clinical events, including death, attributable to cardiovascular disease (2) . This result suggests that even adaptive cardiac remodeling, with its increase role of RAS on myocyte remodeling in hypertension. ACE inhibitors are known to reduce blood pressure in SHRs. To investigate the association between blood pressure reduction and myocyte remodeling, we also examined the effect of bisoprolol, a β1 selective β blockade, in comparison with that of ACE inhibitors in the hypertensive heart.
Methods

Experimental Animals
Female spontaneously hypertensive rats (SHRs) at 12 weeks of age were used in this experiment. The animals were obtained from Sankyo Labo Service Corp. (Tokyo, Japan). They were divided into 4 experimental groups: a control group, group C; low dose perindopril group, group PL; high dose perindopril group, group PH; and bisoprolol group, group B. Blood pressure and cardiac hypertrophy were reduced in SHRs by administration of perindopril at a dosage of 3 mg/kg/day. In this study, water containing perindopril at a dosage of 3 mg/kg/day was given to group PH for 4 weeks, and 10% of this dosage (0.3 mg/kg/day) was given to group PL. Bisoprolol at the dosage of 60 mg/kg/day was administered in drinking water to group B, for 4 weeks. These dosages were determined based on previous reports (6 -8) . The rats were weighed once a week, and the dose of drugs was adjusted to weight and the amount of water consumed. Perindopril was provided by Daiichi Pharmaceutical Co., Ltd. (Tokyo, Japan). All procedures were approved by the Jikei University School of Medicine Animal Care and Use Committee and followed institutional guidelines for animal care.
Hemodynamic Measurements and Echocardiography
Blood pressure and heart rate were measured by a noninvasive method (tail cuff plethysmography). After hemodynamic data were collected, the rats were anesthetized with ketamine (30 mg/kg i.m.) and xylazine (5 mg/kg i.m.) (4). Standard echocardiography techniques using an echo machine with a 7.5 MHz transducer (model Sonos 100; Agilent Technologies, Tokyo, Japan) were used to obtain two-dimensionally targeted M-mode echocardiograms with short-axis views of the left ventricle at or just below the tip of the mitral valve leaflets. The meridional systolic wall stress of LV was calculated from the systolic blood pressure, the echocardiographically measured internal dimension of LV and the wall thickness of LV, as described by Litwin et al. (9) .
Myocyte Isolation and Morphometry
Heparin was injected (3,000 U/kg s.c.) into the rats. The hearts were removed, blotted, weighed and cannulated through the aorta for retrograde perfusion. The aorta was perfused with calcium-free Joklik medium (Sigma Chemical Co., St. Louis, USA) containing 0.01 mmol/l EGTA, followed by Joklik medium plus collagenase (286 U activity/ml; Worthington Biochemical Co., Lakewood, USA). Tissue was minced and poured through 250 µm nylon mesh to collect the myocytes. Isolated cardiac myocytes were fixed immediately with 2% glutaraldehyde phosphate buffer solution in a manner that did not alter cell volume (10) . Myocyte volume was measured using a Coulter Channelyzer (model C-256; Beckman & Coulter Corp., Tokyo, Japan). Cell length, defined as the longest length parallel to the longitudinal axis of the myocyte, was measured in 40 cells from each sample. On the basis of a standard equation for sample size, 40 celllength measurements reduced the sampling error to 3% for all samples (11) . The myocyte CSA was calculated as the cell volume/ cell length. The obtained CSA value thus represented the average value for the entire length of the myocyte.
Statistics
Results are presented as the means SD computed from the average measurements obtained from each group. The Scheffé test was used to examine significant differences observed by ANOVA (12) . Values of p less than 0.05 were considered to indicate statistical significance.
Results
All animals were healthy and exhibited no sign of heart failure. Changes in body weight and heart weight are indicated in Table 1 . There was no significant difference in body weight among the 4 groups at 12 weeks of age. Heart weight and heart weight/body weight ratio in groups PH and PL were lower than in group C at 16 weeks of age. However, there was no significant difference in either heart weight or heart weight/body weight ratio between groups B and C. Hemodynamic data is summarized in Table 2 . There was no significant difference in blood pressure or heart rate among the 4 groups at 12 weeks of age. At 16 weeks of age, the systolic blood pressure in groups PL, PH, and B was significantly lower than that in group C. The blood pressure in groups PL and B was similarly reduced. No significant difference in heart rate was found among groups C, PL, and PH. However, the heart rate in group B was significantly lower than that in group C. Echocardiographic data is indicated in Table 3 . LV wall thickness in groups PL and PH was lower than that in group C at 16 weeks of age. There was no significant difference in fractional shortening of LV among the 4 groups. Systolic wall stress was lower in groups PH and B than in group C. Isolated myocyte data from the LV are indicated in Fig. 1 . LV cell volume was reduced in groups PL and PH compared to that in group C. Cell length was reduced in group PH compared to that in group C, but there was no significant difference between group C and group PL. The myocyte CSA in groups PL and PH was smaller than that in group C. In contrast, no significant difference was found in All rats are SHR. C, control group; PL, low dose perindopril group; PH, high dose perindopril group; B, bisoprolol group; n, number of animals; LVAWd, LV diastolic anterior wall thickness; LVPWd, LV diastolic posterior wall thickness; LVIDd, LV diastolic internal diameter; LVIDS, LV systolic internal diameter; FS, LV fractional shortening. Data were collected from anesthetized rats. Values are expressed as the means SD. p 0.05 compared with C; p 0.05 compared with PL. 
Discussion
ACE inhibitors have been identified as a first choice antihypertensive drug (13) . It has been reported that ACE inhibitors induce a larger reduction in left ventricular mass than diuretics or calcium antagonist (14) . Protein synthesis stimulation by angiotensin II in cultured myocytes emphasizes the importance of the angiotensin II receptor in cardiac hypertrophy (15) . These results suggest that the RAS plays an important role in cardiac hypertrophy. We have previously reported an excessive increase in left ventricular (LV) myocyte cross-sectional area in the pressure-overloaded heart (16). But there have been few reports investigating the effect of ACE inhibitors on myocyte remodeling. Perindopril is a long acting ACE inhibitor and has a high trough/peak ratio close to 1.00, which makes it a very suitable drug for use once a day to control blood pressure (17) . In the present study, we examined the effect of perindopril on myocyte remodeling in the hypertensive heart. We also investigated myocyte remodeling using a β blockade. Heart weight was significantly lower in group PL than in group C, despite the slight reduction in blood pressure in the former group. ACE inhibitors have been reported to decrease heart weight in the hypertrophic heart without a reduction of blood pressure (18, 19) , and these reports supported our present results.
In this study, the blood pressure was markedly reduced in group PH at 16 weeks of age. Unger et al. have reported that perindopril at a dosage of 3 mg/kg/day lowered systolic blood pressure to below 100 mmHg in SHRSP rats (7) . Therefore, we suggest that a dosage of 3 mg/kg/day is a high but not toxic dosage for administration to SHRs.
Perindopril reduced heart weight by 14% and 29% in the low and high dose groups, respectively. Moreover, perindopril also reduced LV myocyte volume by 21% and 47% in the low and high dose groups, respectively. In addition to myocytes, vessels and extra-cellular matrix are also associated with cardiac remodeling. Perindopril has been reported to improve vascular remodeling (20) . Although, in this study, we did not investigate fibrotic and vascular changes in the heart, changes in heart weight were nearly proportional to changes in cell volume. This result suggests that ACE inhibitors have a beneficial effect mainly on myocyte remodeling, since myocytes show no cell division during their maturation period.
In the present study, myocyte remodeling was reversed by perindopril without a reduction in LV wall stress, although bisoprolol did not reverse myocyte remodeling and did cause a reduction in LV wall stress. These results indicate that myocyte remodeling in the hypertensive heart is reversed without a reduction in LV wall stress, and that RAS plays an important role in myocyte remodeling in cardiac hypertrophy induced by hypertension. It has been reported that there is a close relationship between wall stress and cardiac hypertrophy (21) . However, Kai and Ishikawa has reported that lisinopril reversed cardiac remodeling without a reduction in LV wall stress in transgenic hyprertensive mice (22) . This report supports our present results.
It has been reported that an AT1 receptor antagonist decreases left ventricular mass, fibrosis in the myocardium and cell width in the left ventricle in SHRs (23, 24) . Furthermore, Tamura et al. have reported that an AT1 receptor antagonist was more effective than an ACE inhibitor in reversing myo- cyte remodeling in spontaneously hypertensive heart failure (SHHF) rats (25) . These results suggest that the pathway through the AT1 receptor plays an important role in myocyte remodeling in the hypertrophic heart. ACE inhibition also induces activation of bradykinin and this mechanism may be associated with myocyte remodeling. Further studies investigating the effects of AT1 receptor blockers on myocyte remodeling in hypertension are needed to clarify the role of bradykinin.
In the present study, a β blockade could not reverse myocyte remodeling, although it did reduce blood pressure to a level similar to that in group PL. It remains controversial whether or not a β blockade can reverse cardiac remodeling induced by hypertension (26 -29) . In a study by Cherchi et al., a β blockade reduced blood pressure, but did not modify LV mass (27) . This report supports our present experimental results. However, Lauva and Tomanek reported that atenolol reduced LV weight in male SHRs at 4 weeks of age (29) . The discrepancy between these results may be related to the experimental methods used (e.g., the age and sex of rats, or the different drugs used), however, our results indicate that the inhibition of RAS plays a more important role than the suppression of the β adrenergic nervous system in the reversal of myocyte remodeling. Myocyte remodeling in rats with hyperinsulinemia should also be examined, since insulin as well as angiotensin is suggested to stimulate LV hypertrophy (30) .
Perindopril reversed cardiac hypertrophy mainly by reducing the LV myocyte cross-sectional area. We should also consider the fact that long-term pressure overloading develops into cardiac hypertrophy, which leads to heart failure. Therefore, it is important to reverse cardiac hypertrophy as a preventive measure against heart failure. We have reported that arrested myocyte cross-sectional growth may be an early event that precipitates the maladaptive myocyte lengthening associated with the development of heart failure (4, 16) . Although there are limitations in the present study regarding the development of heart failure, we conclude that ACE inhibitors may delay the point at which the myocyte CSA reaches maximum value and ceases to grow in hypertensive heart. As a result, ACE inhibitors may control the maladaptive lengthening of the left ventricular myocytes and thereby protect against heart failure.
Summary
In conclusion, ACE inhibitors reversed cardiac hypertrophy mainly by a reduction in the left ventricular myocyte volume without a reduction in LV wall stress. However, a β blockade reduced LV wall stress but did not reverse myocyte remodeling. These results suggest that the renin-angiotensin system plays an important role in myocyte remodeling in cardiac hypertrophy induced by hypertension.
